Rebuttal to Gammel on Maruyama Vaccine..

[Guest guest]

Hello ,

Read your reply with interest and I should first mention that I am

not working for any company related to this vaccine. I, myself have

cancer and have used the Maruyama vaccine for the past 2.5 years.

Doctors in Canada gave me 2 years to live and I feel stronger,

healthier and better than ever. I am not sure if the vaccine has

been responsible for my evading death by cancer, but I am sure it has

not harmed me in anyway or I would not be here to write you.

If you read the Moss Reports, Dr. Moss states the following about the

Maruyama vaccine:

" For me, one non-specific treatment stands out from the crowd. This

is the SSM or the Maruyama vaccine. "

" In the early 1940's, Chisao Maruyama, MD, director of the Nippon

Medical School in Tokyo, began a 50 yearf clinical experiment with a

form of non-specific active immunotherapy know as the " specific

substance of Maruyama " (SSM) or the Maruyama vaccine. It is made up

of polysaccharides derived from a killed human tuberculosis strain. "

" By now, the Maruyama vaccine has been given to about 400,000

patients in Japan, with no reports of serious side effects. I think

we can presume that it is a relatively safe agent. It appears to be

beneficial to cancer patients of every kind, since its activity

depends on killing cancer cells but on triggering a powerful immune

reaction. If you have a functioning immune system, you can probably

benefit from this treatment. "

" Unlike some of the better known treatments, SSM has been extensively

studies in both the test-tube and the clinic. But although 11 books

have been written about it in Japan, it remains almost entirely

unknown outside the country. "

" In fact different tumors behave differently in their reaction to the

vaccine. Stomach tumors have been observed to either heal with

ulcerations (in early reactions) or to disappear and leave a scar (in

later reactions). The time frame of the treatment was one to seven

months. "

In conclusion, Dr. Ralph Moss is an expert on researching and writing

about cancer treatments available worldwide. He travels and writes

extensively and has written several books on cancer treatment and the

cancer industry. His efforts in researching cancer treatments

available are to steer us (cancer patients) away from what does not

work and to recommend what does work. It appears from his writings

that he strongly supports the use of the Maruyama vaccine.

He is an expert in the field of cancer treatment and has spoken very

positively about the Maruyama vaccine. In Japan 400,000 Japanese

currently or have used the vaccine for cancer treatment.

, I would like to know where you got you your data from as you

do not quote any sources and it appears to be heresay.

Also what is your background. Do you have any studies to back up what

you mentioned below?

Perhaps you might want to debate with 400,000 Japanese....!!!!

Be well.

>

> Hello Ron, and others who are interested in the Maruyama

vaccine.

>

> I have attached contact information for getting the Maruyama

vaccine

> from the Nippon Medical Hospital in Tokyo. When you call the

> hospital the operator will answer in Japanese and just

say, " Maruyama

> vaccine kudasai or Iida sensei kudasai " . I am living and

working in

> Japan so if you have difficulty let me know and I can help

out. Also

> faxing is a good way to contact him at the number listed

below. I

> will call him later this week to find out if he can be

contacted by

> email.

>

> All the best.

>

> Here is one part of an abstract from a paper

titled " Pathological

> Observations during Treatment with the Biological Response

Modifier

> ama Vaccine in Cancer: Implications for Collagen Production

in

> the Preventions of Cancer Invasion an! d Metastasis " . by

Tetsuo

> Kimoto, M.C., Ph.D. published in Cancer Detection and

Prevention

> (1998).

>

> " After treatment with SSM (Maruyama Vaccine), patients and

> experimental animals bearing tumors remained alive with tumors

long

> term. We conclude from these results that SSM acts by inducing

> encapsulation of tumor growths, possibly preventing their

spread and

> metastasis, and that SSM may benefit patient in whom tumor is

> inoprable and resistant to conventional chemotherapy. "

>

> Please let me know if you need more information on the Maruyama

> Vaccine. I will be

> glad to forward it on.

>

> If you are interested in getting the Maruyama vaccine for your

friend

> or anyone else that has cancer you need to fax or call Dr. Iida

at

> the Nippon University Hospital in Tokyo. His fax number is 813-

3824-

> 6400 and phone number is 813-3822-2131. I just spoke with him

on the

> phone and the procedure is! to get the patients attending

doctor to

> write and fax a letter supporting the use of the Maruyama

vaccine (I

> can fax or email you an abstract of the vaccine's

effectiveness -

> from an independant scientific study -if the doctor is unaware

of the

> vaccine.). Once the letter is received the patient has to send

a

> bank draft or bank cheque to the hospital for 30,000 yen about

$360

> CDN. This is enough vaccine for 80 days. The cost also covers

the

> air mail shipping charge.